about
Hidden drug resistant HIV to emerge in the era of universal treatment access in Southeast AsiaThe 15th Bangkok International Symposium on HIV MedicineRisks and safety of pandemic H1N1 influenza vaccine in pregnancy: exposure prevalence, preterm delivery, and specific birth defects.Characteristics of lymphocyte subsets in HIV-infected, long-term nonprogressor, and healthy Asian children through 12 years of ageCancers in the TREAT Asia HIV Observational Database (TAHOD): a retrospective analysis of risk factorsChanges in metabolic toxicity after switching from stavudine/didanosine to tenofovir/lamivudine--a Staccato trial substudy.All-cause mortality of elderly Australian veterans using COX-2 selective or non-selective NSAIDs: a longitudinal study.Increasing use of ADHD medications in pregnancyImmunologic and virologic failure after first-line NNRTI-based antiretroviral therapy in Thai HIV-infected children.Pharmacokinetics of and short-term virologic response to low-dose 400-milligram once-daily raltegravir maintenance therapyAn HIV-1 clade A/E DNA prime, recombinant fowlpox virus boost vaccine is safe, but non-immunogenic in a randomized phase I/IIa trial in Thai volunteers at low risk of HIV infection.Involvement of quinolinic acid in AIDS dementia complex.Correlation of selenium and zinc levels to antiretroviral treatment outcomes in Thai HIV-infected children without severe HIV symptomsTherapeutic Drug Monitoring of Lopinavir in HIV-Infected Children on Second-Line Antiretroviral Therapy in Asia.Socioeconomic factors explain suboptimal adherence to antiretroviral therapy among HIV-infected Australian adults with viral suppression.Prophylactic dissection of level V in primary mucosal SCC in the clinically N positive neck: A systematic review.Poor quality of life among untreated Thai and Cambodian children without severe HIV symptomsEarly versus deferred antiretroviral therapy for children older than 1 year infected with HIV (PREDICT): a multicentre, randomised, open-label trialCD4 cell count criteria to determine when to initiate antiretroviral therapy in human immunodeficiency virus-infected children.Cognitive function and neurodevelopmental outcomes in HIV-infected Children older than 1 year of age randomized to early versus deferred antiretroviral therapy: the PREDICT neurodevelopmental studyComparable performance of conventional and liquid-based cytology in diagnosing anal intraepithelial neoplasia in HIV-infected and -uninfected Thai men who have sex with men.Anal human papillomavirus infection among Thai men who have sex with men with and without HIV infection: prevalence, incidence, and persistence.High prevalence and incidence of high-grade anal intraepithelial neoplasia among young Thai men who have sex with men with and without HIV.A 72-week randomized study of the safety and efficacy of a stavudine to zidovudine switch at 24 weeks compared to zidovudine or tenofovir disoproxil fumarate when given with lamivudine and nevirapine.Human papillomavirus in anal biopsy tissues and liquid-based cytology samples of HIV-positive and HIV-negative Thai men who have sex with men.Macrophage inhibitory cytokine-1/growth differentiation factor-15 as a predictor of colonic neoplasia.Therapeutic drug monitoring of antiretroviral drugs in HIV-infected patients.Safety of the 2011-12, 2012-13, and 2013-14 seasonal influenza vaccines in pregnancy: Preterm delivery and specific malformations, a study from the case-control arm of VAMPSS.Metabolic profiles of individuals switched to second-line antiretroviral therapy after failing standard first-line therapy for treatment of HIV-1 infection in a randomized, controlled trial.De-labelling self-reported penicillin allergy within the emergency department through the use of skin tests and oral drug provocation testing.A Randomized Study of a Single Dose of Intramuscular Cholecalciferol in Critically Ill Adults.Incomplete restoration of Mycobacterium tuberculosis-specific-CD4 T cell responses despite antiretroviral therapy.Does choice of combination antiretroviral therapy (cART) alter changes in cerebral function testing after 48 weeks in treatment-naive, HIV-1-infected individuals commencing cART? A randomized, controlled study.Two patterns of cerebral metabolite abnormalities are detected on proton magnetic resonance spectroscopy in HIV-infected subjects commencing antiretroviral therapy.Efficacy of tenofovir disoproxil fumarate/emtricitabine compared with emtricitabine alone in antiretroviral-naive HIV-HBV coinfection in Thailand.Computer aided prescribing: decision support needs to be evidence based.Quinolinic acid is produced by macrophages stimulated by platelet activating factor, Nef and Tat.Kynurenine pathway metabolism in human astrocytes: a paradox for neuronal protection.Safety of paediatric percutaneous native kidney biopsy and factors predicting bleeding complications.IFN-beta1b induces kynurenine pathway metabolism in human macrophages: potential implications for multiple sclerosis treatment.
P50
Q28474290-72BA233C-84F1-4093-9119-C5C68A50B18EQ29396779-06210E5F-F8E7-4A3B-99DE-02DE67E3B7DBQ30353447-54A4FE0E-D6AD-41CE-8714-D3A45965C495Q34418680-C3E7B372-27E1-4D8F-BEAE-93E1AC305A5DQ34481581-C8DCA417-B5D7-4053-81BE-32614607C448Q34761540-147EA784-BCDF-42F5-AB00-1E6DC289C13EQ34996960-B1A09ADD-4F65-4DC2-8926-89A589C6219EQ35037287-39A3683B-8C41-403F-8500-CC199EAB32E2Q35549604-6AF740F4-56DA-4E61-9E56-D7AC7832C8D6Q35867491-6D59E1F1-89B5-43A2-9B9D-EEA6D86A1D77Q35878653-B09FC993-6BB4-4D0D-877E-F246D2847D7BQ36003890-A21F05CB-6D89-46FE-941D-12328AF958C2Q36139829-B602B123-32F3-4282-B31F-58E018059F55Q36165068-D6B0B531-F951-40DB-86F9-1B7EAEAF6BD7Q36331777-C45E9562-A442-4E4A-B13A-12342C347E7BQ36347524-FDFE5FB6-E631-4E44-BE97-4A83972CE052Q36476634-3B678311-DD88-419E-B9EB-080CFEDA5D01Q36521955-2906DF50-941D-4925-9F79-BB11F41D831BQ36553067-A6FC1670-8190-4A1F-A590-E5D6263302BDQ36876216-C5E4583E-3D03-48CF-A036-35EBEEB62451Q36980003-3D9B7C30-816D-4B42-9307-7FDEA2FDFEAAQ36980208-8698F9D4-E223-46D5-9545-4E6A15C09224Q36995965-61868FD5-7AA8-43CA-8CEC-D4C893AB9FEAQ37025001-F18A85AD-6413-4D2A-865D-155B70C45197Q38673366-3523B3DC-276B-4FE6-932F-9E03DBBA09B6Q38751466-143761BA-324E-47E2-9807-6DBC00D67CD0Q38954109-EAED99DE-7337-4CB3-89CE-4B463F41F926Q39565234-02918FE7-BE92-4970-B65F-451EC061C9CAQ40225806-39EF8220-C9D4-4F8A-9EC9-01F1D0C608BCQ40458837-68E0AE9C-425D-4243-A99E-A9678250B873Q41575576-C28E1DB9-5511-47EB-9AFD-CD211B5ABB82Q42249900-7EB9A35A-1938-45ED-AABB-5A7A20E09DABQ42467116-986F9D02-BEC6-4830-94E4-3A9FA38EB233Q42509249-3AAE6B13-775F-4E5C-9E5E-F46F5AAAF52BQ42909958-CEE267CE-7ED7-4259-BB45-7B22D29C7B7AQ43140602-F8F26B68-786C-4750-9185-5E357B64F54CQ43717545-978FE2CF-4E4C-476D-8BE3-E4DFB969861DQ43718624-11947A93-3B46-4EA9-BCD2-33B0255F8616Q43845346-E7E11977-9057-4BEE-95F6-DA69B07AF8B2Q43859020-1D8AC2E9-E384-43EB-9D42-8371A7C02AD8
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Stephen J. Kerr
@ast
Stephen J. Kerr
@en
Stephen J. Kerr
@es
Stephen J. Kerr
@nl
Stephen J. Kerr
@sl
type
label
Stephen J. Kerr
@ast
Stephen J. Kerr
@en
Stephen J. Kerr
@es
Stephen J. Kerr
@nl
Stephen J. Kerr
@sl
prefLabel
Stephen J. Kerr
@ast
Stephen J. Kerr
@en
Stephen J. Kerr
@es
Stephen J. Kerr
@nl
Stephen J. Kerr
@sl
P106
P1153
7102711578
P21
P31
P496
0000-0002-1919-4525